BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30269021)

  • 1. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
    Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
    Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
    Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
    Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936.
    Toombs J; Panther L; Ornelas L; Liu C; Gomez E; Martín-Ibáñez R; Cox SR; Ritchie SJ; Harris SE; Taylor A; Redmond P; Russ TC; Murphy L; Cooper JD; Burr K; Selvaraj BT; Browne C; Svendsen CN; Cowley SA; Deary IJ; Chandran S; Spires-Jones TL; Sareen D
    Stem Cell Res; 2020 Jul; 46():101851. PubMed ID: 32450543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
    Zhang Y; Li A; Huang CL; Wang G; Wang D
    Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human erythroblast-derived iPSC line using episomal reprogramming system.
    Varga E; Hansen M; Wüst T; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Dec; 25():30-33. PubMed ID: 29040913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
    Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
    Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
    Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
    Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
    Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells.
    Yin X; Li Y; Li J; Li P; Liu Y; Wen J; Luan Q
    Biochem Biophys Res Commun; 2016 May; 473(3):726-32. PubMed ID: 26456649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.
    Wen W; Zhang JP; Chen W; Arakaki C; Li X; Baylink D; Botimer GD; Xu J; Yuan W; Cheng T; Zhang XB
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1.
    Wang Y; Wang Z; Sun H; Shi C; Yang J; Liu Y; Liu H; Zhang S; Zhang L; Xu Y; Zhang J
    Stem Cell Res; 2018 Oct; 32():61-64. PubMed ID: 30216892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.